Home

CTT PHARMACEUTICAL HOLDINGS, INC.

CIK 1035422 · CEO · last filed 2026-09-04

CTT PHARMACEUTICAL HOLDINGS, INC. is a CEO who has filed 58 SEC Form 4 insider transactions across 0 companies. The firm reports its address in Tampa, FL. 13 SEC filings were submitted jointly with STEPHEN W WEATHERS.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

0

Total Filings

58

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
1646 W. SNOW AVE SUITE 138
TAMPA, FL 33606
Phone
(813) 606-0060
State of Incorporation
FL
Formerly Known As
Mindesta Inc. (2011–2015)
INDUSTRIAL MINERALS INC (2002–2011)
PNW CAPITAL INC (2000–2002)
WINCHESTER MINING CORP (2000–2000)
Related Filers
STEPHEN W WEATHERS — 13 joint filings, latest 2004-10-01
William Campbell Birge — 5 joint filings, latest 2012-03-22
Gregory B. Bowes — 5 joint filings, latest 2014-05-27
Douglas G. Perkins — 3 joint filings, latest 2012-03-22
David John Wodar — 3 joint filings, latest 2007-11-07
Paul K Cooper — 2 joint filings, latest 2007-11-26
ROBERT G DINNING — 2 joint filings, latest 2008-10-29
Albert C Zapanta — 2 joint filings, latest 2012-03-27
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
No companies on record.

Recent Filings

58 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-04 — Buy (P) +9,800 $479
2026-09-02 — Buy (P) +3,000 $147
2026-08-31 — Buy (P) +3,500 $172
2026-08-24 — Buy (P) +2,100 $116
2026-08-20 — Buy (P) +11,500 $518
2026-08-19 — Buy (P) +10,000 $590
2026-08-14 — Buy (P) +1,800 $112
2026-08-10 — Buy (P) +7,700 $500
2025-12-17 — Buy (P) +8,300 $456
2025-11-24 — Buy (P) +200,000 $8.0K
Showing 1–10 of 58
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.